Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.208,52
0,31%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Editas Medicine Inc (EDIT) Editas Medicine Inc (EDIT) Notizie

Editas Medicine Inc

EDIT
5,13
-0,36 (-6,56%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202412:04EDGAR2Form 8-K - Current report
14/6/202409:01GLOBEEditas Medicine Reports New Safety and Efficacy Data from..
14/6/202409:00GLOBEEditas Medicine Announces New Safety and Efficacy Data from..
06/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202422:21EDGAR2Form 144 - Report of proposed sale of securities
31/5/202422:20EDGAR2Form 144 - Report of proposed sale of securities
31/5/202422:18EDGAR2Form 8-K - Current report
22/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202412:00GLOBEEditas Medicine Preclinical Data Highlights Advancement of..
08/5/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:29IHMARKETNEWSU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet..
08/5/202413:08EDGAR2Form 8-K - Current report
08/5/202413:00GLOBEEditas Medicine Announces First Quarter 2024 Results and..
02/5/202413:00GLOBEEditas Medicine Announces First Quarter 2024 Results..
01/5/202414:00GLOBEEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T..
22/4/202422:31GLOBEEditas Medicine to Present Pre-clinical Data Demonstrating..
06/3/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:58EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:13EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202422:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202413:06EDGAR2Form 8-K - Current report
28/2/202413:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
21/2/202413:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
14/2/202414:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202415:00GLOBEEditas Medicine to Participate in Upcoming Investor..
08/1/202414:15GLOBEEditas Medicine Highlights 2024 Anticipated Milestones and..
03/1/202413:00GLOBEEditas Medicine to Present at the 42nd Annual J.P. Morgan..
13/12/202318:48DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202315:49DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202315:02EDGAR2Form 8-K - Current report
13/12/202315:00GLOBEEditas Medicine and Vertex Pharmaceuticals Enter into..
11/12/202322:23EDGAR2Form 8-K - Current report
11/12/202318:00GLOBEEditas Medicine Announces New EDIT-301 Safety and Efficacy..
07/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:10EDGAR2Form 8-K - Current report
16/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202312:06EDGAR2Form 8-K - Current report
03/11/202312:00GLOBEEditas Medicine Announces Third Quarter 2023 Results and..
02/11/202314:12GLOBEEditas Medicine to Present Clinical Data from the RUBY and..
Apertura: 5,46 Min: 5,03 Max: 5,4898
Chiusura: 5,49

La tua Cronologia

NASDAQ
EDIT
Editas Medicine
ASX
AT1
Atomo Diagnostics
BIT
P1IZB9
BNP Paribas Issuance
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network